A significant issue to arise from the reports is the extent to which the framework for the operation of LRECs has been confused by the development of the purchaser-provider split. The paper concludes with suggestions for remedying the situation.
Introduction
There have been several accounts of the functioning of Local Research Ethics Committees. An early and influential report was by Nicholson (1) , which dealt specifically with the issue of research on children.
Other reports have described practice in the UK (2) and Scotland (3) , the experiences of lay-members of LRECs (4) , and of researchers trying to pilot the protocol for a multi-centre study through 30 different LRECs (5) . Meanwhile both Gilbert et al (6) and Neuberger (7) have undertaken reviews of LREC
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Research ethics committees; annual reports. practice, the first by post and the second by observation and interview. One of the conclusions to be drawn from these reports was that LRECs were characterised by their variability rather than by any clear consistency of practice.
The Department of Health or its predecessors have at various times produced guidelines concerning the establishment, responsibilities and practice of LRECs. Most recently, the department issued an updated set of guidelines (8), setting out expectations for the establishment and functioning of LRECs, for implementation by District Health Authorities (DHAs) by March 1992. For the first time it was made clear that each LREC should produce an annual report for its establishing authority, and that the report should be available for public inspection. It was through this mechanism that LRECs were to have some degree of accountability for their work.
Aims and objectives
This paper is the report of a study undertaken for the Centre of Medical Law and Ethics at King's College, London. There were three objectives: (i) to assess whether the Department of Health guidelines concerning the existence of LRECs and their publication of annual reports were being met; (ii) to assess, on the basis of information published in the annual reports, the level of adherence to the guidelines relating to the constitution and operation of LRECs, and (iii) to assess the information from the annual reports in the context of current debate about the role of LRECs, with particular reference to issues of accountability.
Design of the study The Department of Health (DoH) guidelines suggest that there should normally be one LREC for every District Health Authority. The guidelines envisage that there might occasionally be two (but no more than two) and suggest that the circumstances in which this might be appropriate could be 'where there is a particularly high burden of work, perhaps originating from two research centres' (9 
Results (I) LRECS AND THEIR ANNUAL REPORTS
The guidelines require that each year the LREC should submit a report to the DHA. It should give the names of committee members, the numbers of meetings held and should include a list of proposals considered by the committee, including whether they were approved, approved after amendment, rejected or withdrawn (8).
One hundred and forty-three health authority LRECs were circulated in the first instance and we were informed of a further 52 LRECs. Of the 143 districts, annual reports were received from 110, there was an indication from 25 that no report had been produced, and despite reminders, no response from 5. Three committees no longer existed following administrative changes at health authority level. Including all ofthe other ways of acquiring reports described above, 145 annual reports were received in total. The jurisdictional basis of these LRECs is shown in Table 1 . It should be noted that several of the 'district-wide' committees from whom we received reports are no longer district-wide, following mergers of health authorities, whilst others no longer exist.
The 'annual' reports covered a variety of periods, ranging from under 6 months to over 18 months. However, the vast majority (119 (82 per cent)) were for a 12-month period. The length of the reports also varied greatly, from one side of A4 paper to substantial bound documents of 40 or more pages.
Eighty-nine reports (61 per cent) gave the full title of each protocol considered, together with a clear indication of the outcome of each application. A substantial minority (55 (38 per cent)) did not provide these details, offering only totals for the number of projects received, and those accepted or rejected. One committee advised us that the whole of their report was confidential, and several others that the details (title, etc) of each project and the decision about it could not be released. Table 3 makes use only of those reports (119) which cover a 12-month period. The first two columns show the number of meetings held by the 104 LRECs providing this information. There is clearly very great variation in the number of meetings held; but this variation in workload is seen even more clearly in the numbers of protocols reviewed by these committees. The second half of Table 3 shows that some of the 1 14 committees providing this information handle a very large number of protocols indeed in a twelve-month period.
Many reports indicated that there was some concern about the workload of members of the committee, with 35 referring to this issue; for example, a meeting of one committee lasted over 61/2 hours.
Although several alluded to an increase in the number of protocols submitted, very few gave any quantitative data to illustrate their concern. In a small number of cases the report suggested there was a very significant shortfall in the degree of administrative or secretarial support available. The guidelines require (para 2. 1) that the DHA should provide administrative support; it seems that a few districts are not providing this support effectively.
The guidelines suggest (para 2.14) that LRECs should require immediate notification of unusual or unexpected results which raise questions about the safety of the research, and also suggest that reports from investigators on successes or difficulties in recruiting subjects may provide the committee with useful feedback on the acceptability of the project to patients and volunteers. A very few reports indicate that the occasional project was terminated because of unexpected side-effects or difficulty with recruitment, but this seems to be a rare occurrence. More broadly, 23 per cent of the LRECs do refer to the existence of some form of routine monitoring of protocols which has been approved by the committee. This monitoring normally takes the form of requiring six-or twelve-monthly reports from the investigator on the progress or conclusion of the research.
One aspect of the working practices of LRECs on which the guidelines are silent is the question of whether commercial organisations sponsoring a protocol should be expected to contribute to the costs of the ethical review process. The Department of Health has recently stated that it is not, in principle, against LRECs charging (in its letter accompanying an EU Directive on Medical Devices) (1 2). The majority of annual reports do not refer to this issue, but it is clear that several LRECs do make a charge for consideration of some protocols, and that these charges vary considerably, from £25 to £250 per protocol. The annual reports suggest that there is considerable variation in the style of working of the committees. For example, there was firm evidence from the reports that 28 of the committees routinely invite those who had submitted protocols to attend the meeting at which they were discussed. However, additional comments suggested that for several committees this would be the case only where some potential difficulty had been apprehended before the meeting.
(IV) ISSUES OF IMPORTANCE TO LRECS
Many chairmen in their annual report take the opportunity to comment on issues which are of concern to them. Perhaps the most significant set of comments relate to the uncertainties caused for some committees by the organisational changes in the NHS. The merger of health authorities has inevitably caused some difficulties and confusion, and the development of NHS trusts has also raised questions about the remit of some committees. The implications of the purchaser-provider split within the NHS was the basis of several comments; this issue is pursued in the discussion section of this paper.
The question of how to provide for the ethical review of multi-centre research has long been an issue of concern (5,13). The guidelines start from the proposition that each LREC is free to arrive at its own decision in all cases, but then suggest voluntary arrangements whereby one LREC is nominated to consider the issue on behalf of them all (14) . A few of the annual reports indicate that steps are being taken in this direction, although it is clear that the arrangements normally result only in an advisory opinion which would not bind the individual LRECs. In a more general sense, 26 reports (18 per cent) made some reference to the issue of multi-centre research. The most frequently expressed view was that, however much time might be saved by having some element of central or regional overview of such protocols, local circumstances were so important that they should never be ignored when it came to implementing research in a specific setting.
Discussion
One overriding impression from reading the annual reports is how seriously LRECs take their task. There is nothing to indicate that committees which may fail to adhere to the guidelines in terms of their composition or manner of working in any way compromise their concern for the interests of either researchers or subjects. Indeed, there is an argument that the guidelines themselves are unhelpful in that in some respects they are too prescriptive (why should they assume that a committee of more than a dozen members is always to be avoided?), and in other respects inadequately detailed (no mention of charging commercial organisations for the work involved).
(I) ACCOUNTABILITY Many of the points which arise from a consideration of the reports relate to the issues of accountability and the need to reassure patients, and the public, that medical research is subject to effective ethical review. The guidelines make it clear (para 1.1) that the decision on whether research goes ahead must come from the NHS body (trust, HDA, or FHSA) under whose auspices the research would take place. This perspective has recently been re-stated (10). However, there is very little in the LRECs' reports to indicate that in practice the effective decision is taken by anyone other than the LREC itself. It is an oddity of the structure envisaged by the guidelines that the only detailed public review of research proposals comes from the annual report of what is in theory an advisory body, rather than from the body which is formally responsible for the final decision.
Nevertheless, it remains important that the annual reports of LRECs should contain all the information which would serve to reassure the public. In particular, and as a minimum, there seems to be no reason for not giving the outcome of each individual application considered by the committee. And, of course, we can see no defence for the view of the one committee which told us that its entire report was confidential.
The principle of accountability suggests that the names of committee members should be known, and A few reports indicated that a junior doctor was a member of the committee. Since it will often be junior medical staff who enrol patients into research studies this seems a desirable extension of the more typical range of membership. We also believe that it would be sensible to extend the guidelines' suggestion of a lay-member unconnected professionally with health care from one to at least two of the membership of the committee. Other 'lay'-members, such as hospital chaplains, may have a valuable contribution to make, but the objective of creating an effective, independent element in the review process suggests that they might serve in addition to two truly lay people.
It is good to find that many committees make efforts, as described earlier, to follow up the research which they approve. However, the reports generally give little indication of how successful these efforts are. None of the reports makes any reference to the active monitoring of research whilst it is in progress. Active monitoring would go beyond current practice in order to ensure that research is carried out as originally approved. At present, many committees spend a good deal of their time considering, for example, how subjects' consent should be obtained, but little is done to ensure that patients are always approached and informed in precisely the agreed manner, let alone that the research itself is conducted in accordance with the approved protocol.
(II) RESOURCES We have referred earlier to the need for all LRECs to be properly supported for all the necessary requirements of their task; the onus for ensuring that this happens must be on the DHA which is responsible for the committee. This obligation will principally comprise the provision of administrative support. However, the need for training of LREC members must also receive attention. Several committees referred to various aspects of training in the reports, although no report suggested the existence of a plan for its provision. Various initiatives are under way in this area: we hope that the issue of training for LRECs and their individual members will receive sustained attention in the future. Perhaps the single most significant issue which arises from these annual reports is the impact of NHS re-organisation on the system of ethical review. The guidelines were issued before NHS trusts became the main basis for the delivery of health care, though the principles of the new organisational arrangements were already established (15) .
It is clear that the proposal that a district LREC should be used to provide ethical research advice to all NHS bodies within the district (para 2.1) has resulted in considerable confusion, for both districts and trusts. In the internal market, where income for hospitals has become of considerable significance, there is a new set of direct pressures affecting the carrying out of sponsored research. If a major objective of an effective system of ethical review is to maintain and increase public confidence that all decisions are being made for laudable reasons, then there is a strong argument for maintaining the basis of review of hospital-based research in an external body, namely the district.
On the other hand, it could be argued that the purchasing authority is not necessarily the most appropriate body to approve or refuse applications to carry out research. It seems out of place with the remainder of the system that a body advising a major purchaser of services should concern itself with what are in effect the minutiae of the clinical affairs of a provider unit. In some circumstances it might seem invidious to researchers in one institution to have their work approved, or not, after detailed review by clinicians from another trust who sit on the district LREC.
Confusing picture
It is clear that the guidelines did not adequately envisage the issues which would arise for LRECs out of the recent changes in the NHS. We cannot overemphasize the confusing picture which has developed following the merger of many district authorities, and the development of the purchaserprovider split. There are districts where a merger has resulted in the creation of a new LREC, but where the old LRECs are still functioning, never having been told to disband. In some districts a committee that was essentially a hospital-based organisation (though performing a district-wide function), with administrative support provided by the district, has found that support withdrawn when the hospital achieved trust status, and the chairman unable to discover if his or her committee is still supposed to exist or to whom it should report. In other districts such committees have continued explicitly as trustbased committees, though their relation to newly established district-wide committees in the same district remains uncertain. In yet other districts, the committee acts as an umbrella focal point, receiving reports from all the institutions within the district (at a maximum, 14), some of which currently are trusts and some of which are not, but each of which has its own REC. It is fair to point out that confusion is far from universal. In many merged districts clear decisions have been taken to merge, or sometimes not to merge, old LRECs, and ethical review seems to be proceeding coherently with everyone clear about reporting and accountability.
Nevertheless, it is important that ground rules should now be considered for the situation which has developed and that any new proposals should take account of the diversity described above. In our view it is desirable that, as the 1991 guidelines recommended, in most situations the basic template should remain the single district-wide LREC. However, the existence of some degree of flexibility to take account of local circumstances cannot be avoided. The minimum requirement must be that a DHA should be made aware of the existence of all LRECs operating within its geographical area, and that the district and the Department of Health should maintain a list of all such LRECs. The most important substantive point is that each DHA should authorise and approve the creation, constitution and membership of every LREC within its district, should provide the requisite administrative support, and should receive an annual report from each of them. Where an LREC presently exists without the formal approval of the DHA, this approval should be sought. Without such a requirement it will be more difficult for those engaged in medical research to convince the public of the independence and accountability of the process of ethical review.
